About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Effective Communication between Radiation and Medical Oncologist May Improve Concurrent CRT in Unresectable Stage III NSCLC
By
AstraZeneca Oncology
FEATURING
Roy Decker
,
Mark Socinski
,
Jhanelle Gray
,
Mary Grizzard
By
AstraZeneca Oncology
FEATURING
Roy Decker
,
Mark Socinski
,
Jhanelle Gray
,
Mary Grizzard
914 views
November 15, 2019
Comments are disabled for this content.
Related Content
AUTOPLAY
ON
06:27
AstraZeneca Oncology
Importance of Proactive AE Management and Patient Education for Conc…
Feat.
R. Decker,
J. Gray,
J. Chang,
V. Sherry,
V. Villaflor,
M. Socinski,
K. Higgins
06:01
AstraZeneca Oncology
Advances in Radiation Technology May Improve Concurrent CRT in Unres…
Feat.
R. Decker,
M. Socinski,
J. Chang,
K. Higgins
04:40
AstraZeneca Oncology
Even Patients With Locally Advanced Stage III NSCLC May Be Treated W…
Feat.
R. Decker,
J. Gray,
J. Chang,
M. Socinski,
K. Higgins
18:47
Total Health
Updates in the Management of NSCLC: Systemic Therapy Year in Review
Feat.
W. Iams
11:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical…
Feat.
J. West
17:20
Total Health
2024 Intervention Selection & Sequencing in Early Stage NSCLC
Feat.
J. Porter
09:40
John Conibear
PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
26:42
Total Health
ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 AS…
Feat.
J. Bauman
17:57
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Expert Discussion on New Treatment Options…
Feat.
D. Carbone,
B. Stiles
07:38
GRACE
How Does PD-L1 Score Affect Treatment Options for NSCLC
Feat.
S. Patel,
T. Leal,
P. Iyengar,
A. Desai,
C. Kim,
J. Rotow
21:40
OncoAlert
Thoracic Surgery Updates From Recent NSCLC Trials
Feat.
B. Stiles
13:01
Nebraska Oncology Society
ASCO 2022 on Immunotherapy Updates in Advanced NSCLC
Feat.
J. Brahmer
20:42
2023 Evolution Conference
Treatment Strategies for Early Stage NSCLC
Feat.
N. Seetharamu
01:42
ecancer
ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analysi…
Feat.
R. Herbst
08:55
Insights from 2023 ASCO® Annual Meeting
Surgical Aspects in the Treatment of Locally Advanced NSCLC
Feat.
G. Veronesi
13:43
Total Health
NSCLC Highlights - Best of ASCO® 2023 Meeting
Feat.
M. Das
18:14
Janakiraman Subramanian
Understanding KRAS G12C Positive Lung Cancer
10:29
NYU Langone
FDA Approval of Adagrasib in KRAS G12Cm NSCLC
Feat.
J. Sabari
12:16
ecancer
ASCO® 2023 Summary: "Analysis of Key Studies in Lung Cancer - A…
Feat.
L. Raez
20:46
Total Health
Perioperative Therapy for Early Stage NSCLC - Best of Lung 2023
Feat.
S. Kazmi
07:29
ESMO 2022 Conference Coverage
ESMO 2022 Updated Results From ADAURA: Osimertinib as Adjuvant Thera…
Feat.
T. John
13:51
Fox Chase Cancer Center
Adjuvant Treatment of NSCLC: ADAURA in Context
Feat.
M. Edelman
